Juno shares surge on news of $1 billion payment from Celgene
Permalink

Juno shares surge on news of $1 billion payment from Celgene

Biotech startup Juno Therapeutics (NASDAQ:JUNO) was up 21% in midday trading Tuesday as analysts weighed…

Continue Reading →